From the Department of Infectious Diseases, Aarhus University Hospital , Aarhus , Denmark.
Infect Dis (Lond). 2015 Aug;47(8):517-22. doi: 10.3109/23744235.2015.1026932. Epub 2015 Apr 1.
Vaccination guidelines from the Danish Health and Medicines Authority recommend vaccination of all men who have sex with men (MSM) against hepatitis B virus (HBV). The only existing data on HBV infection in Danish MSM stem from 1984: 58% of MSM attending venereal clinics in Copenhagen had a prior and 4% had a chronic HBV infection. The aim of this study was to provide up-to-date data on the prevalence of HBV infection and vaccination coverage among Danish MSM.
At the venereal clinic at Aarhus University Hospital, 1525 consecutive patients received a questionnaire covering risk group and vaccination status; moreover, HBV serology was performed. Prevalence proportions of serological signs of vaccination, infection, etc. were stratified according to self-reported risk group and vaccination status.
In total, 141 patients were MSM. Among these, 14% (CI = 9-21%) were vaccinated, 7% (CI = 3-13%) had a prior infection and 1.4% (CI = 0.2-5%) were HBsAg positive. In patients recalling three doses of vaccination, 18% (CI = 11-26%) were anti-HBs negative and 0.8% (CI = 0.02-5%) were HBsAg positive. Similar data for other risk groups and the total clientele are presented.
This study presents the first Scandinavian data on the prevalence of HBV infection and vaccination among MSM since the introduction of the vaccine. Danish health authorities should evaluate whether a carrier frequency of 1.4% and a vaccination coverage of 14% in MSM is acceptable or warrants intensified focus on vaccination. Prospective vaccination campaigns should consider prevaccination testing, since 18% of patients recalling three doses of vaccination were anti-HBs negative.
丹麦卫生和药品管理局的疫苗接种指南建议对所有男男性行为者(MSM)进行乙型肝炎病毒(HBV)疫苗接种。丹麦 MSM 中 HBV 感染的唯一现有数据可追溯至 1984 年:在哥本哈根的性病诊所就诊的 MSM 中,有 58%的人既往感染过 HBV,4%的人患有慢性 HBV 感染。本研究旨在提供丹麦 MSM 中 HBV 感染和疫苗接种率的最新数据。
在奥胡斯大学医院的性病诊所,对 1525 名连续患者进行了一项问卷调查,涵盖了风险群体和疫苗接种状况;此外,还进行了 HBV 血清学检测。根据自我报告的风险群体和疫苗接种状况,对血清学疫苗接种、感染等指标的流行比例进行分层。
共有 141 名患者为 MSM。其中,14%(95%置信区间:9-21%)接受了疫苗接种,7%(95%置信区间:3-13%)既往感染过 HBV,1.4%(95%置信区间:0.2-5%)HBsAg 阳性。在回忆接种过三剂疫苗的患者中,18%(95%置信区间:11-26%)抗-HBs 阴性,0.8%(95%置信区间:0.02-5%)HBsAg 阳性。还提供了其他风险群体和总就诊人群的类似数据。
本研究提供了自疫苗推出以来,斯堪的纳维亚地区首次关于 MSM 中 HBV 感染和疫苗接种的流行率数据。丹麦卫生当局应评估 MSM 中 1.4%的携带率和 14%的疫苗接种率是否可以接受,或者是否需要加强疫苗接种的重点。前瞻性疫苗接种活动应考虑进行疫苗接种前检测,因为回忆接种过三剂疫苗的患者中有 18%的抗-HBs 阴性。